Weekly Test-21-FSO-PART B
Weekly Test-21-FSO-PART B
Weekly Test-21-FSO-PART B
1. What percentage of the global nutraceuticals market is concentrated in the United States,
Europe, and Japan?
a) 70%
b) 80%
c) 90%
d) 93%
3. Which segment dominates the Indian nutraceuticals market with a 68% share?
a) Dietary supplements
b) Functional food and beverage
c) Sports and energy drinks
d) Weight loss products
4. What is the predicted expansion rate of the Indian nutraceuticals market by 2019-2020?
a) 15%
b) 18%
c) 20%
d) 25%
7. What is the main motivation for the growth of the nutraceuticals and functional foods
market?
a) Decreasing healthcare costs
b) Rising cases of chronic diseases
c) Government regulations
d) Decreasing consumer awareness
10. Which nutrient is commonly associated with weight management, cardiac care, immunity,
and digestive health in nutraceuticals?
a) Vitamin C
b) Conjugated linoleic acid (CLA)
c) Calcium
d) Iron
11. Liquid nutraceuticals such as enhanced water, energy juice, and sports drinks present
substantial growth prospects due to their:
a) Long shelf life
b) High sugar content
c) Convenience and ease of consumption
d) Low nutritional value
12. What emerging field is expected to have a significant impact on the future of nutraceuticals
and functional foods, allowing for the alteration of food composition?
a) Food biotechnology
b) Nutritional psychology
c) Nutrigenomics
d) Food nanotechnology
15. What is the focus of current efforts by government organizations, food scientists, and private
research institutes in the field of nutraceuticals and functional foods?
a) Increasing food production
b) Reducing healthcare costs
c) Enhancing food flavors
d) Decreasing consumer awareness
16. Which of the following is NOT a safety concern mentioned in the development of
nutraceuticals and functional foods?
a) Ensuring safety for all consumer groups
b) Maintaining precise quantities of ingredients
c) Adding unsafe ingredients into functional foods
d) Increasing the risk for certain consumer groups
17. According to the passage, what are health claims based on?
a) Consumer preferences
b) Scientific evidence
c) Marketing strategies
d) Government regulations
18. What regulatory framework governs the manufacturing and marketing of nutraceuticals and
functional foods in India?
a) Food and Drug Administration
b) Food Safety and Standard Act (2006)
c) World Health Organization
d) European Food Safety Authority
19. What is one of the challenges mentioned in the development of nutraceuticals and
functional foods?
a) Short regulatory procedures
b) Low risk for food companies
c) Difficulty in getting country regulations
d) Lack of scientific evidence for health claims
20. Which company's products are mentioned as clear examples of standing out in the market
with scientific proof of health benefits?
a) Nestle
b) Coca-Cola
c) PepsiCo
d) McDonald's
21. What is the primary goal of functional foods and nutraceuticals in countering the burden of
the healthcare system?
a) Providing treatment for diseases
b) Reducing prevention methods
c) Promoting prevention over treatment
d) Increasing healthcare costs
22. What is mandatory in demonstrating the potential health benefits of certain foods?
a) Compliance with government regulations
b) Scientific validation of health-diet relationships
c) Increase in marketing efforts
d) Reduction in consumer preferences
23. What is a potential risk associated with copying "free" ingredients easily?
a) Limited competitive benefits
b) Increased consumer awareness
c) Higher market share
d) Reduced production costs
25. How are nutraceuticals and functional foods described in the epilogue?
a) Harmful to human health
b) Essential components of a healthy lifestyle
c) Unregulated and unsafe
d) Focused solely on treatment of diseases
Answer keys:
1. d) 93%
2. b) South India
3. b) Functional food and beverage
4. c) 20%
5. b) DSM
6. d) 13%
7. b) Rising cases of chronic diseases
8. b) Nutrigenomics
9. c) Modifying diet plans based on genetics
10. b) Conjugated linoleic acid (CLA)
11. c) Convenience and ease of consumption
12. a) Food biotechnology
13. b) Preventing diseases such as iron deficiency anemia and blindness
14. d) Enhancing food flavors
15. b) Reducing healthcare costs
16. d) Increasing the risk for certain consumer groups
17. b) Scientific evidence
18. b) Food Safety and Standard Act (2006)
19. c) Difficulty in getting country regulations
20. a) Nestle
21. c) Promoting prevention over treatment
22. b) Scientific validation of health-diet relationships
23. a) Limited competitive benefits
24. d) Identifying their role in disease prevention
25. b) Essential components of a healthy lifestyle